salicylic acid 20 MG/ML Topical Solution [Clenziderm]

RxCUI: 1235208
RxNorm name: salicylic acid 20 MG/ML Topical Solution [Clenziderm]
Term type: SBD
Status: Active
Updated: 2026-07-19 06:51:57

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 012012
Active start: 012012
Multiple ingredient: NO
Branded: YES

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
salicylic acid	20 MG / 1 ML	salicylic acid	salicylic acid

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Topical Solution	316986

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
salicylic acid	9525

Source Vocabulary Codes#

Code type, Values, Count table
Code type	Values	Count	Category
RXNAV_STR	Clenziderm M.D. 2 % Pore Therapy	1	NAMES
RxNorm Name	salicylic acid 20 MG/ML Topical Solution [Clenziderm]	1	NAMES
RxNorm Synonym	2 linked values Clenziderm 20 MG/ML Topical Solution Clenziderm M.D. 2 % Pore Therapy	2	NAMES
TTY	SBD	1	ATTRIBUTES
SPL_SET_ID	3 linked values 08ba9ea8-73fd-472b-9cc4-67df167352ec 08c1a55e-a376-4cd6-896f-0ad2068a1fc0 7710e51a-dd3a-4f44-8c97-c089c6817cb0	3	CODES
RxCUI	1235208	1	CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDC	Product NDC	Name	Labeler	Application
62032-612-04	62032-612	CLENZIDERM PORE THERAPY SALICYLIC ACID	Obagi Cosmeceuticals LLC	M006

Drugs@FDA Applications#

Application, NDC, Name table
Application	NDC	Name	Marketing category	Labeler
M006	62032-612	CLENZIDERM PORE THERAPY SALICYLIC ACID	OTC MONOGRAPH DRUG	Obagi Cosmeceuticals LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 4 matching rows.

NDC11, Source, Active table
NDC11	Source	Active
62032061204	rxnav_ndcs	yes
00187610204	rxnav_historical
62032011060	rxnav_historical
69269011060	rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Obagi Skintrinsiq Clarifiying Protocol	SALICYLIC ACID, TITANIUM DIOXIDE, AND ZINC OXIDE	Obagi Cosmeceuticals LLC	08ba9ea8-73fd-472b-9cc4-67df167352ec	2025-03-21	Warnings	Exact identifier ndc (package): 62032-612-04 ndc11 (package): 62032061204 rxcui: 1235208
clenziderm m.d. system acne therapeutic system	SALICYLIC ACID AND BENZOYL PEROXIDE	Obagi Cosmeceuticals LLC	7710e51a-dd3a-4f44-8c97-c089c6817cb0	2025-03-19	Warnings	Exact identifier ndc (package): 62032-612-04 ndc11 (package): 62032061204 rxcui: 1235208
CLENZIDERM PORE THERAPY ACNE TREATMENT	SALICYLIC ACID	Obagi Cosmeceuticals LLC	08c1a55e-a376-4cd6-896f-0ad2068a1fc0	2025-01-01	Warnings	Exact identifier ndc (package): 62032-612-04 ndc (product): 62032-612 ndc11 (package): 62032061204 rxcui: 1235208

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 5 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
08ba9ea8-73fd-472b-9cc4-67df167352ec	CLENZIderm M.D. 2 % Pore Therapy Topical Solution [PSN] · salicylic acid 20 MG/ML Topical Solution [Clenziderm] [SBD] · Clenziderm 20 MG/ML Topical Solution [SY] · Clenziderm M.D. 2 % Pore Therapy [SY]	4	3	Obagi ® Skintrinsiq™ Clarifiying Protocol Kit	20250321
7710e51a-dd3a-4f44-8c97-c089c6817cb0	CLENZIderm M.D. 2 % Pore Therapy Topical Solution [PSN] · salicylic acid 20 MG/ML Topical Solution [Clenziderm] [SBD] · Clenziderm 20 MG/ML Topical Solution [SY] · Clenziderm M.D. 2 % Pore Therapy [SY]	4	3	CLENZIDERM M.D.™ SYSTEM ACNE THERAPEUTIC SYSTEM	20250319
08c1a55e-a376-4cd6-896f-0ad2068a1fc0	CLENZIderm M.D. 2 % Pore Therapy Topical Solution [PSN] · salicylic acid 20 MG/ML Topical Solution [Clenziderm] [SBD] · Clenziderm 20 MG/ML Topical Solution [SY] · Clenziderm M.D. 2 % Pore Therapy [SY]	4	3	CLENZIDERM PORE THERAPY ACNE TREATMENT	20250101
934ec314-1ab7-45ee-a2fe-8bff3ff981b6	CLENZIderm M.D. 2 % Pore Therapy Topical Solution [PSN] · salicylic acid 20 MG/ML Topical Solution [Clenziderm] [SBD] · Clenziderm 20 MG/ML Topical Solution [SY] · Clenziderm M.D. 2 % Pore Therapy [SY]	4	1	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM	20120510
852f01d0-5859-4482-a1fa-91827c964001	CLENZIderm M.D. 2 % Pore Therapy Topical Solution [PSN] · salicylic acid 20 MG/ML Topical Solution [Clenziderm] [SBD] · Clenziderm 20 MG/ML Topical Solution [SY] · Clenziderm M.D. 2 % Pore Therapy [SY]	4	1	OBAGI ® CLENZIderm M.D.™ Pore Therapy	20111215

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set ID	Title	Manufacturer	Effective
08ba9ea8-73fd-472b-9cc4-67df167352ec	Obagi ® Skintrinsiq™ Clarifiying Protocol Kit	Obagi Cosmeceuticals LLC \| G.S.COSMECEUTICAL USA, INC. \| Denison Pharmaceuticals, LLC \| Swiss-American CDMO, LLC \| TENCO ASSEMBLIES, INC	20250321
7710e51a-dd3a-4f44-8c97-c089c6817cb0	CLENZIDERM M.D.™ SYSTEM ACNE THERAPEUTIC SYSTEM	Obagi Cosmeceuticals LLC \| G.S.COSMECEUTICAL USA, INC. \| Denison Pharmaceuticals, LLC	20250319
08c1a55e-a376-4cd6-896f-0ad2068a1fc0	CLENZIDERM PORE THERAPY ACNE TREATMENT	Obagi Cosmeceuticals LLC \| G.S.COSMECEUTICAL USA, INC. \| Denison Pharmaceuticals, LLC	20250101
37d89871-9a5f-4927-9c7d-a450ab56ac70	OBAGI ® MEDICAL CLENZIderm M.D.™ Pore Therapy Refreshing CLENZIderm M.D.™ Pore Therapy unclogs and refines pores and clears away dead skin cells with 2% salicylic acid.	Valeant Pharmaceuticals North America LLC \| Ei INC.	20171130
d8dcb9c1-764c-4786-96cf-57f24f36ceda	CLENZIDERM M.D. SYSTEM	Valeant Pharmaceuticals North America LLC \| Ei INC.	20150608
934ec314-1ab7-45ee-a2fe-8bff3ff981b6	CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM	OMP, INC. \| PURETEK CORPORATION \| Ei INC.	20120510
852f01d0-5859-4482-a1fa-91827c964001	OBAGI ® CLENZIderm M.D.™ Pore Therapy	OMP, INC. \| PURETEK CORPORATION \| Ei INC.	20111215

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	S01BC	Antiinflammatory agents, non-steroids	ATC1-4		salicylic acid
ATC	D01AE	Other antifungals for topical use	ATC1-4		salicylic acid
MEDRT	D020156	Salicylic Acid	CHEM	has_ingredient	salicylic acid
MEDRT	D000152	Acne Vulgaris	DISEASE	may_treat	salicylic acid
MEDRT	D012628	Dermatitis, Seborrheic	DISEASE	may_treat	salicylic acid
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	salicylic acid
MEDRT	D017492	Keratosis, Seborrheic	DISEASE	may_treat	salicylic acid
MEDRT	D011565	Psoriasis	DISEASE	may_treat	salicylic acid
MEDRT	D012536	Scalp Dermatoses	DISEASE	may_treat	salicylic acid
MEDRT	D014860	Warts	DISEASE	may_treat	salicylic acid
MEDRT	N0000009915	Unknown Cellular or Molecular Interaction	MOA	has_moa	salicylic acid
MEDRT	N0000009974	Increased Skin Keratinization	PE	has_pe	salicylic acid

Group, Type, Concept table
Group	Type	Concept	Source
BN	BN	Clenziderm	rxnav_allrelated
DF	DF	Topical Solution	rxnav_allrelated
DFG	DFG	Topical Product	rxnav_allrelated
GPCK	GPCK	{1 (240 ML) (benzoyl peroxide 25 MG/ML Medicated Liquid Soap) / 1 (120 ML) (salicylic acid 20 MG/ML Topical Solution) / 1 (60 ML) (sulfur 50 MG/ML Topical Solution) } Pack	rxnav_allrelated
GPCK	GPCK	{1 (28000 MG) (benzoyl peroxide 0.05 MG/MG Topical Gel) / 1 (127000 MG) (salicylic acid 20 MG/ML Medicated Liquid Soap) / 1 (147 ML) (salicylic acid 20 MG/ML Topical Solution) } Pack	rxnav_allrelated
GPCK	GPCK	{1 (3000 MG) (benzoyl peroxide 0.05 MG/MG Topical Gel) / 1 (28000 MG) (salicylic acid 20 MG/ML Medicated Liquid Soap) / 1 (26 ML) (salicylic acid 20 MG/ML Topical Solution) } Pack	rxnav_allrelated
GPCK	GPCK	{1 (47 ML) (benzoyl peroxide 50 MG/ML Topical Lotion) / 1 (118 ML) (salicylic acid 20 MG/ML Medicated Liquid Soap) / 1 (148 ML) (salicylic acid 20 MG/ML Topical Solution) } Pack	rxnav_allrelated
IN	IN	salicylic acid	rxnav_allrelated
SBD	SBD	salicylic acid 20 MG/ML Topical Solution [Clenziderm]	rxnav_allrelated
SBDC	SBDC	salicylic acid 20 MG/ML [Clenziderm]	rxnav_allrelated
SBDF	SBDF	salicylic acid Topical Solution [Clenziderm]	rxnav_allrelated
SBDG	SBDG	Clenziderm Topical Product	rxnav_allrelated
SCD	SCD	salicylic acid 20 MG/ML Topical Solution	rxnav_allrelated
SCDC	SCDC	salicylic acid 20 MG/ML	rxnav_allrelated
SCDF	SCDF	salicylic acid Topical Solution	rxnav_allrelated
SCDG	SCDG	salicylic acid Topical Product	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	ACTIVATED	04/01/2025
ATTRIBUTES	AVAILABLE_STRENGTH	20 MG/ML
ATTRIBUTES	GENERAL_CARDINALITY	SINGLE
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
NAMES	Prescribable Synonym	CLENZIderm M.D. 2 % Pore Therapy Topical Solution
SOURCES	Source	Metathesaurus FDA Structured Product Labels